NIH VideoCast - CCR Grand Rounds: Targeting Myelodysplasia – RNA Biology in and In Vivo Modeling of Myelodysplastic Syndromes

Skip Navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

CCR Grand Rounds: Targeting Myelodysplasia – RNA Biology in and In Vivo Modeling of Myelodysplastic Syndromes

Loading... Loading video...

150 Views

Air date:	Friday, June 7, 2024, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 150 (78 Live, 72 On-demand)
Category:	Special
Runtime:	00:57:16
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	CCR Grand RoundsTargeting Myelodysplasia – RNA Biology in and In Vivo Modeling of Myelodysplastic SyndromesStephanie Halene, M.D., Dr. Med.Arthur H and Isabel Bunker Professor of Medicine Chief, Section of HematologyYale School of MedicineFriday, June 7, 202412:00–1:00 p.m.Lipsett AmphitheaterAlso available to view via NIH Videocast.Dr. Halene’s laboratory studies how mutations in splicing factors and perturbations in RNA modifications contribute to hematologic malignancies such as myelodysplasia and leukemia. Dr. Halene, in collaboration with the Flavell laboratory in the Yale School of Medicine Department of Immunobiology, has developed the first efficient xenotransplantation model in humanized mice to study myelodysplasia and enable testing of novel drug treatments.For conference-related questions please contact ccrconferences@mail.nih.gov.

NLM Title:	Targeting myelodysplasia : RNA biology and in vivo modeling of myelodysplastic syndromes / Stephanie Halene.
Author:	Halene, Stephanie. National Institutes of Health (U.S.). Clinical Center,
Publisher:
Abstract:	(CIT): CCR Grand RoundsTargeting Myelodysplasia - RNA Biology in and In Vivo Modeling of Myelodysplastic SyndromesStephanie Halene, M.D., Dr. Med.Arthur H and Isabel Bunker Professor of Medicine Chief, Section of HematologyYale School of MedicineFriday, June 7, 202412:00-1:00 p.m.Lipsett AmphitheaterAlso available to view via NIH Videocast.Dr. Halene"s laboratory studies how mutations in splicing factors and perturbations in RNA modifications contribute to hematologic malignancies such as myelodysplasia and leukemia. Dr. Halene, in collaboration with the Flavell laboratory in the Yale School of Medicine Department of Immunobiology, has developed the first efficient xenotransplantation model in humanized mice to study myelodysplasia and enable testing of novel drug treatments.For conference-related questions please contact ccrconferences@mail.nih.gov.
Subjects:	Models, Genetic Molecular Targeted Therapy Mutation Myelodysplastic Syndromes--genetics Myelodysplastic Syndromes--therapy RNA Splicing Factors--genetics
Publication Types:	Lecture Webcast

NLM Classification:	WH 385
NLM ID:	9918879457306676
CIT Live ID:	54902
Permanent link:	https://videocast.nih.gov/watch=54902

Related Videos...